KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Bionano Genomics (BNGO) over the last 6 years, with Q3 2025 value amounting to $1.8 million.

  • Bionano Genomics' Other Non-Current Assets rose 34050.0% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 34050.0%. This contributed to the annual value of $2.8 million for FY2024, which is 6293.9% down from last year.
  • As of Q3 2025, Bionano Genomics' Other Non-Current Assets stood at $1.8 million, which was up 34050.0% from $2.1 million recorded in Q2 2025.
  • Bionano Genomics' Other Non-Current Assets' 5-year high stood at $11.4 million during Q2 2024, with a 5-year trough of $235000.0 in Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $697000.0 (2021), whereas its average is $2.1 million.
  • As far as peak fluctuations go, Bionano Genomics' Other Non-Current Assets soared by 275200.0% in 2024, and later crashed by 8168.83% in 2025.
  • Over the past 5 years, Bionano Genomics' Other Non-Current Assets (Quarter) stood at $749000.0 in 2021, then surged by 222.3% to $2.4 million in 2022, then soared by 207.83% to $7.4 million in 2023, then crashed by 62.94% to $2.8 million in 2024, then plummeted by 36.02% to $1.8 million in 2025.
  • Its Other Non-Current Assets was $1.8 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.4 million in Q1 2025.